S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|U.S. FDA Approves New Indication for the Use of XTANDI® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer|
|U.S. FDA Approves New Indication for the Use of XTANDI(R) (Enzalutamide) Capsules for Patients With Metastatic Castration-Resistant Prostate Cancer|
|Medivation Reports Second Quarter Financial Results and Provides Corporate Update|
|Ambit Biosciences Announces Second Quarter 2014 Operating Results|
|Ironwood Pharmaceuticals Provides Second Quarter 2014 Investor Update|
|RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development|
|XenoPort Reports Second Quarter Financial Results|
|Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results|
|Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol|
|XenoPort to Present Data for Novel Fumarate Analog XP23829 at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston|
Click above to view more mutual fund data and stats for alpmy - Astellas Pharma Inc ADR.